Investigational Drug Information for Ralinepag
✉ Email this page to a colleague
What is the development status for investigational drug Ralinepag?
Ralinepag is an investigational drug.
There have been 6 clinical trials for Ralinepag.
The most recent clinical trial was a Phase 2 trial, which was initiated on October 29th 2020.
The most common disease conditions in clinical trials are Familial Primary Pulmonary Hypertension, Pulmonary Arterial Hypertension, and Hypertension. The leading clinical trial sponsors are United Therapeutics, Arena Pharmaceuticals, and Everstar Medicines (Shanghai) Limited.
There is one US patent protecting this investigational drug and fifty-eight international patents.
Summary for Ralinepag
| US Patents | 1 |
| International Patents | 58 |
| US Patent Applications | 41 |
| WIPO Patent Applications | 29 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 2 (2020-10-29) |
| Vendors | 40 |
Recent Clinical Trials for Ralinepag
| Title | Sponsor | Phase |
|---|---|---|
| A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH | United Therapeutics | Phase 3 |
| A Study of Ralinepag in Healthy Chinese Audlt Subjects | Everstar Medicines (Shanghai) Limited | Phase 1 |
| A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | United Therapeutics | Phase 3 |
Clinical Trial Summary for Ralinepag
Top disease conditions for Ralinepag
Top clinical trial sponsors for Ralinepag
International Patents for Ralinepag
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Ralinepag | Australia | AU2017261372 | 2036-05-05 | ⤷ Sign Up |
| Ralinepag | Canada | CA3023278 | 2036-05-05 | ⤷ Sign Up |
| Ralinepag | China | CN107847398 | 2036-05-05 | ⤷ Sign Up |
| Ralinepag | European Patent Office | EP3452003 | 2036-05-05 | ⤷ Sign Up |
| Ralinepag | European Patent Office | EP3981392 | 2036-05-05 | ⤷ Sign Up |
| Ralinepag | Hong Kong | HK1249728 | 2036-05-05 | ⤷ Sign Up |
| Ralinepag | Japan | JP2019520866 | 2036-05-05 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
